HomeProductsDosimetryPLANET® Dose

PLANET® Dose

Multi-radionuclide platform for voxel-based personalized dosimetry

PLANET® Dose offers fully integrated 3D personalized dosimetry for both SIRT and MRT. It provides pre & post-implantation dosimetry, estimation of time-integrated activity, allows the possibility of comparing between treatment planning and validation control dose maps, as well as the consolidation of multi-treatment stages.

Advanced oncology features (PLANET® Onco) are integrated for treatment planning and patient follow-up to bring an “end-to-end”, versatile and vendor-neutral solution, with a streamlined clinical workflow. 

SIRT
90Y & 166Ho

  • Support of all microspheres: 90Y resin & glass, 166Ho
  • Liver-lung shunt fraction assessment
  • Empirical, BSA and partition models
  • Interactive activity scaling for planning
  • 3D voxel-based dosimetry
  • Simplified workflow: Plan the activity -> Assess the planned & delivered doses -> Compare & consolidate dose maps

MRT
177Lu & 131I

  • Adapted to 177Lu (PSMA, PRRT) & 131I (mIBG, thyroid) therapies
  • Support of other radionuclides on request*
  • Unlimited number of time points
  • Residence time and cumulated activity
  • Availability of a wide range of fitting models
  • Definition of the curve at the injection time
  • Behavior of the tail of the curve
  • 3D voxel-based dosimetry
  • Multiple workflows: single-time point (Prior cycle, or User-defined/Hänscheid) & multiple-time points (Hybrid 2D-3D or full 3D)

Shared dosimetry features

  • Voxel S-Values dose kernel convolution algorithm 
  • Local energy deposition method 
  • Tissue density correction 
  • 4D management (image series and contours) 
  • Advanced dose analysis tools (value picker, dose profile, isodose display, Dose Volume Histograms, …) 
  • Structure creation from user defined dose threshold 
  • Dosimetry comparison 
  • Consolidation of multiple treatment stages: internal dosimetry and/or external beam radiotherapy 
  • DICOM RT-Dose import/export

Oncology features included

  • Multi-modality image display and fusion
  • Rigid and deformable registration
  • Automatic segmentation (lungs, functional tumor, etc.)
  • Advanced contouring
  • Volume Of Interest quantification
  • Partial volume effect correction
  • Therapy response assessment (RECIST, PERCIST)
  • Reporting and traceability

*For beta and gamma emitters only